86691-07-8

Basic information

• Product Name: 2-amino-5-(trifluoromethyl)benzenethiol
• Synonyms: 2-amino-5-(trifluoromethyl)benzenethiol
• CAS NO: 86691-07-8
• Molecular Weight: 193.193
• Mol File: 86691-07-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-amino-5-(trifluoromethyl)benzenethiol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-5-(trifluoromethyl)benzenethiol(86691-07-8)
• EPA Substance Registry System: 2-amino-5-(trifluoromethyl)benzenethiol(86691-07-8)

Safety Data

• Hazardous Substances Data: 86691-07-8(Hazardous Substances Data)

Upstream product

• 131106-70-2 6-(trifluoromethyl)benzo[d]thiazole 
• 455-14-1 4-trifluoromethylphenylamine 
• 90774-69-9 4-aminobenzotrifluoride hydrochloride 
• 1736-72-7 1-(4-(trifluoromethyl)phenyl)thiourea 
• 777-12-8 2-amino-6-trifluoromethyl-1,3-benzothiazole 

Downstream Products

• 126764-52-1 2-Chloromethyl-6-trifluoromethyl-benzothiazole 
• 1314518-69-8 C₅₄H₅₀F₆N₆O₂S₂ 
• 1314518-77-8 C₅₄H₄₈B₂F₁₀N₆O₂S₂ 

Relevant articles and documents

2-AMINOPYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF

The disclosure provides an aminopyrimidine derivative for preventing and treating diseases related to IDH mutation, a preparation method and use thereof. Specifically, the disclosure provides a compound of Formula I, a stereoisomer, racemate thereof, or pharmaceutically acceptable salt thereof. The compound of the general Formula I has isocitrate dehydrogenase 1 (IDH1) inhibitory activity and can treat cancer induced by IDH1 mutation.

ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME

The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity,methods of treating inflammatory conditions such as Crohn's disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-γ in a subject.

Synthesis of 7-chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1,4-benzothiazines as antimicrobial agents

7-Chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1,4-benzothiazines have been synthesized by 2-amino-5-fluoro/5-trifluoromethyl/5-chloro-3-trifluoromethyl benzenethiols condensed with β-diketone/β-ketoesters in the presence of DMSO involving oxidative cyclization. Pharmacological activities have also been included.